Buscar resultados de ensayos clínicos
Giant Lymph Node Hyperplasia - 21 Studies Found
Estado | Estudiar |
Withdrawn |
Nombre del estudio: Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease Condición: Giant Lymph Node Hyperplasia Fecha: 2006-08-08 Intervenciones: Drug: Valganciclovir valganciclovir open label, two 450mg tablets orally, twice a day |
Active, not recruiting |
Nombre del estudio: A Study to Evaluate the Safety of Long-term Treatment With Siltuximab in Patients With Multicentric Castleman's Disease Condición: Multicentric Castleman's Disease Fecha: 2011-04-21 Intervenciones: Drug: Siltuximab Type=exact number, unit=mg/kg, number=11, form=intravenous solution, route=intravenous. |
Completed |
Nombre del estudio: A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment Condición: Castleman's Disease Fecha: 2010-08-13 Intervenciones: Drug: tocilizumab [RoActemra/Actemra] maintenance dose |
Active, not recruiting |
Nombre del estudio: A Study to Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease Condición: Multicentric Castleman's Disease Fecha: 2009-11-30 Intervenciones:
|
Recruiting |
Nombre del estudio: Tocilizumab for KSHV-Associated Multicentric Castleman Disease Condición:
|
Terminated |
Nombre del estudio: Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy Condición:
Fecha: 2005-08-04 Intervenciones: Drug: Rituximab |
Recruiting |
Nombre del estudio: TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial Condición: Multicentric Castleman Disease Fecha: 2017-01-31 Intervenciones: Drug: Thalidomide, cyclophosphamide and prednisone |
Completed |
Nombre del estudio: A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease Condición:
|
Recruiting |
Nombre del estudio: Castleman Disease Collaborative Network Biobank Condición:
|